)
Atea Pharmaceuticals (AVIR) investor relations material
Atea Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 18, 2026, with voting available online or virtually.
Shareholders are encouraged to review proxy materials and vote by June 17, 2026.
Voting matters and shareholder proposals
Election of three Class III directors: Jerome Adams, Howard Berman, and Barbara Duncan, with board recommending a vote in favor.
Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory (non-binding) approval of named executive officer compensation, with board recommending a vote in favor.
Provision for other business to be transacted as may properly come before the meeting.
Board of directors and corporate governance
Board recommends all director nominees for election to Class III positions.
- Proxy covers director elections, auditor ratification, and performance-based executive pay.AVIR
Proxy filing27 Apr 2026 - Phase III HCV and HEV programs advance, topline results in 2026, cash $301.8M, net loss $158.4M.AVIR
Q4 20255 Mar 2026 - Pivotal COVID-19 and HCV trial results due late 2024; $502.2M cash funds operations into 2027.AVIR
Q2 20242 Feb 2026 - Strong phase II HCV results and a pivotal COVID-19 trial set up major milestones for late 2024.AVIR
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Late-stage HCV and preclinical HEV programs advance with strong clinical and market momentum.AVIR
44th Annual J.P. Morgan Healthcare Conference15 Jan 2026 - HCV Phase 2 results due December; $482.8M cash funds operations through 2027.AVIR
Q3 202415 Jan 2026 - Phase 2 trials showed 98% SVR12 in adherent HCV patients, advancing to global phase 3.AVIR
7th Annual Evercore ISI HealthCONx Healthcare Conference11 Jan 2026 - 98% cure rate in HCV phase II; phase III to enroll 1,600 patients globally.AVIR
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Phase 3 HCV program launches April 2025 after 98% SVR12 and $454.7M cash runway.AVIR
Q4 202424 Dec 2025
Next Atea Pharmaceuticals earnings date
Next Atea Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)